Each peptide has distinct receptor targets, pharmacological characteristics, and areas of scientific interest
Injections deliver a quick, concentrated boost in a smaller dose
February 19th, 2024: Federal panel consolidates 55 Ozempic lawsuits into multidistrict litigation The Ozempic Lawsuit is developing, with legal actions focusing on claims related to severe gastrointestinal injuries attributed to the use of Ozempic and similar GLP-1 receptor agonist drugs
identify an unexpected metabolic underlying mechanism for this disease: the lipid chaperone fatty-acid-binding protein 5 (FABP5) aggravates psoriatic inflammation by driving keratinocytes into ferroptosis, a form of regulated cell death induced by iron-dependent lipid peroxidation (Fig
GLP-1 drugs are going to play a key role in spearheading blood cancer prevention. For more information: Abhay Singh, MD, MPH , can be reached at [email protected].